STOCK TITAN

Neuberger High Yield Strategies Fund Inc. 424B Filings

NHS NYSE

Every 424B that Neuberger High Yield Strategies Fund Inc. (NHS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow NHS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NHS filings page.

Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. is conducting a transferable rights offering to issue 10,463,948 shares of Common Stock upon exercise of Rights. One Right will be issued per outstanding share on the Record Date of March 23, 2026; three Rights are required to purchase one new share (1-for-3). The Rights expire at 5:00 PM Eastern on April 15, 2026 unless extended and are expected to trade under the symbol NHS RT.

The estimated Subscription Price shown is $6.84 (based on a 95% formula), with estimated gross proceeds of $71,573,404 and estimated net proceeds of approximately $68,418,335 after an estimated $650,000 of offering expenses and a Dealer Manager fee equal to 3.50% of the Subscription Price. Rights exercised are irrevocable; shares issued will not be record date stock for the Fund’s April 30, 2026 monthly distribution.

Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. files a base prospectus registering $167,633,695 of common stock and transferable subscription rights to issue shares and/or rights in one or more offerings. The Fund's NAV per share was $7.25 and the last reported NYSE American sale price was $7.58 (a 4.55% premium) as of February 19, 2026.

The Fund had 31,386,322 shares outstanding as of February 19, 2026. As of October 31, 2025, the Fund reported loans of $61,000,000 and Mandatory Redeemable Preferred Shares, Series D with an aggregate liquidation preference of $40,000,000, representing a total leverage ratio of 30.2%; the Series D MRPS mature on September 29, 2026.

Rhea-AI Summary

Neuberger High Yield Strategies Fund Inc. updates its prospectus to reflect a corporate name change and portfolio management transitions.

Effective December 18, 2025, the Fund changed its name from Neuberger Berman High Yield Strategies Fund Inc. to Neuberger High Yield Strategies Fund Inc. Effective December 31, 2025, Joseph Lind will expand his role to Co-Head of Special Situations and will cease portfolio management responsibilities to the Fund on or about December 31, 2026. Also effective December 31, 2025, Steve Ruh will join as a co-portfolio manager alongside Mr. Lind and Christopher Kocinski. The prospectus language for the "Management of the Funds – Portfolio Managers" section is replaced to reflect these role changes.